Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions

Journal of Oral Pathology and Medicine

Volumn 26, Issue 5, 1997, Pages 206-210

  Berta, Giovanni N ^a   Ghezzo, Franco ^a   D'Avolio, Antonio ^a   Zulian, Paolo ^a   Carbone, Vincenzo ^a   Racca, Silvia ^a   Vercellino, Vittorio ^a   Di Carlo, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Calcyclin; Oral cancer; PCR; Proliferation gene

Indexed keywords

EID: 0031148164     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1997.tb01225.x     Document Type: Article

References (42)

1. PARKIN DM, PISANI P, FERLAY J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. MCGUIRT WF. Cancer of the upper aerodigestive tract. Basic principles and concepts. Postgrad Med 1986; 80: 77-96.
3. BOYLE P, MACFARLANE GJ, ZHENG T, MAISONNEUVE P, EVSTIFEVA T, SCULLY CS. Recent advances in epidemiology of head and neck cancer. Curr Opin Oncol 1992; 4: 471-7.
4. FIELD JK, SPANDIDOS DA. Expression of oncogenes in human tumours with special reference to the head and neck region. J Oral Pathol Med 1987; 16: 97-107.
5. PILLAI R, REDDIAR KS, BALARAM P. Oncogene expression and oral cancer. J Surg Oncol 1991; 47: 102-8.
6. HOELLINGER J, SCHULER CF. Localization of H-ras mRNA in oral squamous cell carcinomas. J Oral Pathol Med 1989; 18: 74-8.
7. SARANATH D, CHANG SE, BHOITE IT, et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991; 63: 573-8.
8. SAKAI E, TSUSHIDA N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992; 7: 927-33.
9. LARGEY JS, MELTZER SJ, YIN J, NORRIS K, SAUK JJ, ARCHIBALD DW. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993; 71: 1933-7.
10. BOSCH FX, UDVARHELY N, VENTER E, et al. Expression of the histone- H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur J Cancer 1995; 29A: 1454-61.
11. NYLANDER K, STENLING R, GUSTAFSSON H, ZACKRISSON B, Roos G. P53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 1995; 75: 87-93.
12. KIARIS H, SPANDIDOS DA, JONES AS, VAUGHAN ED, FIELD JK. Mutations, expression and generic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck. Br J Cancer 1995; 72: 123-8.
13. PARTRIDGE M, GULLIK, WJ, LANGDON JD, SHERIFF M. Expression of epidermal growth factor receptor on oral squamous cell carcinoma. Br J Oral Maxillofac Surg 1988; 26: 381-9.
14. ISHITOYA J, TORIYAMA M, OGUCHI N, et al Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989; 59: 559-62.
15. SHIN DM, VORAVUD N, Ro JY, LEE JS, HONG WK, HITTELMAN WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst 1993; 85: 971-8.
16. CALABRETTA B, BATTINI R, KACZMAREK L, DE RIEL JK, BASERGA R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 1986; 261: 12628-32.
17. CALABRETTA B, VENTURELLI D, KACZMARHK. L, et al Altered expression of Gl-specific genes in human malignant myeloid cells. Proc Natl Acad Sci USA 1986; 83: 1495-8.
18. GHEZZO F, LAURET E, FERRARI S, BASERGA R. Growth factor regulation of the promoter for calcyclin, a growth-regulated gene. J Biol Chem 1988; 263: 4758-63.
19. MURPHY LC, MURPHY LJ, TSUYUKI D, DUCKWORTH ML, SHIU RPC. Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J Biol Chem 1988; 263: 2397-401.
20. 2+-binding protein. FEBS Lett 1989; 254: 141-4.
21. TONINI GP, CASALANO A, CARA A, Di MARTINO D. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res 1991; 51: 1733-7.
22. WETERMAN MAJ, VAN MUIJEN GNP, BLOEMERS HPJ, RUITER DJ. Expression of calcyclin in human melanocytic lesions. Cancer Res 1993; 53: 6061-6.
23. BRINCK U, GABIUS HJ, ZENG FY, GERKE V. Differential expression of calcyclin and its accessible ligands in various types of cutaneous tumors. J Dermatol Sci 1995; 10: 181-90.
24. ZENG F-Y, GERKE V, GABIUS H-J. Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart, Int J Biochem 1993; 25: 1019-27.
25. VANGRONINGEN JJM, WETERMAN MAJ, SWART GWM, BLOEMERS HPJ. Functional analysis of the human calcyclin gene promoter in a panel of human melanoma cell lines. Biochem Biophys Res Commun 1995; 213: 1122-31.
26. LADANYI M, CAVALCHIRE G, MORRIS SW, DOWNING J, FILIPPA DA. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol 1994; 145: 1296-300.
27. BABA M, NAKANISHI O, SATO W, et al. Relation between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells. Cancer Chemother Pharmacol 1995; 36: 361-7.
28. HERMANEK P, SOBIN LH. TNM classification of malignant tumors, 4th edn. Berlin: Springer-Verlag, 1987: 13-8.
29. CHOMEZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
30. GARSON JA, TEDDER RS, BRIGGS M, et al Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-22.
31. FERRARI S, CALABRETTA B, DE RIEL JK, et al. Structural and functional analysis of a growth-regulated gene, the human calcyclin. J Biol Chem 1987; 262: 8325-32.
32. CAPON DJ, CHEN KY, LEVINSON AD, SEEBURG PH, GOEDDEL DV. Complete nucleotide sequence of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 1983; 302: 33-7.
33. MARASCHI F, HELMS S, SHIELS A, et al Enhancer-facilitated expression of prokaryotic and eukaryotic genes using human histone gene 5' sequences. Biochem Cell Biol 1986, 64: 277-89.
34. NAKAJIMA-IIJIMA S, HAMADA H, REDDY P, KAKUNAGA T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 1985; 82: 6133-7.
35. SAIKI RK, SCHARF S, FALOONA F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-4.
36. WANG AM, DOYLE MV, MARK DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86: 9717-21.
37. ARMITAGE P. Statistical methods in medical research. Whitstable (Kent): Black-well Scientific Publications, 1977: 118-22.
38. KAWASAKI ES, WANG AM. Detection of gene expression. In: ERLICH HA ed. PCR technology. New York: Stockton Press, 1989; 89-104.
39. KOTSINAS A, KIARIS H, SPANDIDOS DA. A method to detect and quantitate the expression of normal versus mutant H-ras transcripts at codon 12. Intl J Oncol 1994; 5: 479-83.
40. GUO X, CHAMBERS AF, PARFETT CC, et al. Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic ras-transformed NIH/3T3 cells. Cell Growth Differ 1990; 1: 333-8.
41. BARGER SW, WOLCHOCK SR, VAN ELDIK LJ. Disulfide-linked S100β dimers and signal transduction. Biachim Biophys Acta 1992; 1160: 102-12.
42. GONG Y, ALKAHALAF B, MURPHY LJ, MURPHY LC. Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Cell Growth Differ 1992; 3: 847-53.